IK-248

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIK-248
Drug Alias Name6 (10)4alpha-v/beta-6-Erk2 pathway inhibitor (INTER-K)IK-248
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionExtracellular-signal-regulated kinase 2 inhibitorsIntegrin alpha-V/beta-6 inhibitors
TargetsIntegrin alpha-V/beta-6Extracellular-signal-regulated kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesINTER-K Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesINTER-K Pty Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A